Cancer Family
Urinary System Neoplasm
CI-CAN-00000379Explore in graph →
Non-malignant964 active trials28 approved drugs109 evidence items
- NCIt
- C3431
Loading cancer entity…
Cancer Family
CI-CAN-00000379Explore in graph →
Clinical trials
4,238 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06215976 | The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer | unknown | Phase 4 | 78 | Cairo UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT05949424 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE) | unknown | Phase 4 | 30 | University Medical Center GroningenOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT05723991 | Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma | unknown | Phase 4 | 36 | Chunguang yang (101937)OTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05488353 | A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma | unknown | Phase 4 | 48 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Aug 4, 2022 | clinicaltrials |
| NCT05220124 | A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma | unknown | Phase 4 | 190 | Tianjin Medical University Second HospitalOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT05068180 | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | unknown | Phase 4 | 200 | RenJi HospitalOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT03831321 | The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy | unknown | Phase 4 | 144 | Taha UçarOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT03790384 | Sequential Combination Therapy in Bladder Cancer(MITOBCG) | unknown | Phase 4 | 140 | Azienda Ospedaliera "Sant'Andrea"OTHER | 0 | Dec 31, 2018 | clinicaltrials |
| NCT03274284 | Chemoradiotherapy for Recurrent T1G3 Bladder Cancer | unknown | Phase 4 | 20 | Assiut UniversityOTHER | 0 | Sep 11, 2017 | clinicaltrials |
| NCT02696733 | Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach | unknown | Phase 4 | 100 | Medical University of WarsawOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT03038321 | Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? | unknown | Phase 4 | 150 | Mansoura UniversityOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT03147586 | Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy | unknown | Phase 4 | 100 | Mansoura UniversityOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT03029676 | The Assessment of POCD After TURBT Under Spinal Anesthesia | unknown | Phase 4 | 200 | Medical University of WarsawOTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT02443844 | Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression | unknown | Phase 4 | 40 | Diskapi Teaching and Research HospitalOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT01876836 | Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications(C-LMA) | unknown | Phase 4 | 120 | Diskapi Yildirim Beyazit Education and Research HospitalOTHER_GOV | 1 | Jun 13, 2013 | clinicaltrials |
| NCT00777504 | Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors | unknown | Phase 4 | 30 | Radboud University Medical CenterOTHER | 1 | Sep 16, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Aug 20, 2024source: clinicaltrials